Summary of Significant Accounting Policies - Recent Accounting Pronouncements (Details) - Collaboration Agreement - Incyte - USD ($) $ in Millions |
12 Months Ended | |
---|---|---|
Jan. 08, 2018 |
Dec. 31, 2017 |
|
Recently Adopted Accounting Pronouncements | ||
Revenue recognized under the agreement | $ 0.0 | |
Subsequent event | ||
Recently Adopted Accounting Pronouncements | ||
Up-front consideration | $ 10.0 | |
Up-front consideration, cash | 2.5 | |
Up-front consideration, pre-paid research funding | 7.5 | |
Maximum target selection milestone payments and option exercise fees the Company is eligible to receive | 54.0 | |
Maximum development and regulatory milestone payments the Company is eligible to receive for each of the validated targets | 50.0 | |
Maximum commercial milestone payments the Company is eligible to receive for each of the validated targets if products arising from collaboration are approved | $ 65.0 |
X | ||||||||||
- Definition The maximum amount of commercial milestone payments the Company is eligible to receive for each of the validated targets under the collaboration agreement if products arising from the collaboration are approved. No definition available.
|
X | ||||||||||
- Definition The maximum amount of development and regulatory milestone payments the Company is eligible to receive for each of the validated targets under the collaboration agreement. No definition available.
|
X | ||||||||||
- Definition The maximum target selection milestone payments and option exercise fees the Company is eligible to receive under the collaboration agreement. No definition available.
|
X | ||||||||||
- Definition The amount of up-front cash consideration. No definition available.
|
X | ||||||||||
- Definition Represents the amount of up-front consideration. No definition available.
|
X | ||||||||||
- Definition The amount of up-front consideration received in the form or pre-paid research funding. No definition available.
|
X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available.
|
X | ||||||||||
- Definition The amount of consideration recognized during the period for the milestone or milestones. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|